These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 37119365)
1. A structural model of the iRhom-ADAM17 sheddase complex reveals functional insights into its trafficking and activity. Kahveci-Türköz S; Bläsius K; Wozniak J; Rinkens C; Seifert A; Kasparek P; Ohm H; Oltzen S; Nieszporek M; Schwarz N; Babendreyer A; Preisinger C; Sedlacek R; Ludwig A; Düsterhöft S Cell Mol Life Sci; 2023 Apr; 80(5):135. PubMed ID: 37119365 [TBL] [Abstract][Full Text] [Related]
2. The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release. Düsterhöft S; Kahveci-Türköz S; Wozniak J; Seifert A; Kasparek P; Ohm H; Liu S; Kopkanova J; Lokau J; Garbers C; Preisinger C; Sedlacek R; Freeman M; Ludwig A Cell Mol Life Sci; 2021 Jun; 78(11):5015-5040. PubMed ID: 33950315 [TBL] [Abstract][Full Text] [Related]
3. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex. Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M Elife; 2018 Jun; 7():. PubMed ID: 29897336 [TBL] [Abstract][Full Text] [Related]
4. Status update on iRhom and ADAM17: It's still complicated. Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158 [TBL] [Abstract][Full Text] [Related]
5. Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17. Zhao Y; Dávila EM; Li X; Tang B; Rabinowitsch AI; Perez-Aguilar JM; Blobel CP Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361585 [TBL] [Abstract][Full Text] [Related]
6. iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE. Oikonomidi I; Burbridge E; Cavadas M; Sullivan G; Collis B; Naegele H; Clancy D; Brezinova J; Hu T; Bileck A; Gerner C; Bolado A; von Kriegsheim A; Martin SJ; Steinberg F; Strisovsky K; Adrain C Elife; 2018 Jun; 7():. PubMed ID: 29897333 [TBL] [Abstract][Full Text] [Related]
7. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids. Matthews AL; Noy PJ; Reyat JS; Tomlinson MG Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961 [TBL] [Abstract][Full Text] [Related]
18. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells. Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826 [TBL] [Abstract][Full Text] [Related]
19. Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals. Lu F; Zhao H; Dai Y; Wang Y; Lee CH; Freeman M Mol Cell; 2024 Jun; 84(11):2152-2165.e5. PubMed ID: 38781971 [TBL] [Abstract][Full Text] [Related]
20. iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding. Maretzky T; McIlwain DR; Issuree PD; Li X; Malapeira J; Amin S; Lang PA; Mak TW; Blobel CP Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11433-8. PubMed ID: 23801765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]